Exercise or conversion by Joel Kanter of 1250 shares of WaferGen Bio subject to Rule 16b-3
WaferGen Bio systems Inc insider trading alert for exercise of restricted stock units by Joel Kanter, the corporate stakeholder, on October 2, 2017. This event was filed by Wafergen Biosystems Inc with SEC on 2010-12-20. Statement of changes in beneficial ownership - SEC Form 4
Filed transaction by Wafergen Biosystems Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Story MomentumThis story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.
Similar stores for WaferGen Bio
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
|Hide View All Next||Launch Piotroski F Score|